1. Home
  2. Stocks
  3. Lalpathlab Share Price
  • Chart
  • F&O
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Dr. Lal Pathlabs Share Price Dr. Lal Pathlabs

    Mid Cap
    ₹2,326.75
    6.7 (0.29%)
    16 April, 2024 09:37 BSE: 539524 NSE: LALPATHLABISIN: INE600L01024

    Start SIP in Dr. Lal Pathlabs

    Start SIP

    Dr. Lal Pathlabs Performance

    Day Range

    • Low 2,283
    • High 2,330
    ₹ 2,326

    52 Week Range

    • Low 1,873
    • High 2,767
    ₹ 2,326
    • Open Price2,300
    • Previous Close2,320
    • Volume27846

    Dr. Lal Pathlabs Share Price

    • Over 1 Month 14.73%
    • Over 3 Month -6.63%
    • Over 6 Month -8.92%
    • Over 1 Year 21.58%

    Dr. Lal Pathlabs Key Statistics

    P/E Ratio 58.9
    PEG Ratio 1.7
    Market Cap Cr 19,423
    Price to Book Ratio 11.4
    EPS 34.9
    Dividend 1
    Relative Strength Index 57.7
    Money Flow Index 87
    MACD Signal -3.36
    Average True Range 61.12

    Dr. Lal Pathlabs F&O

    Dr. Lal Pathlabs Futures Dr. Lal Pathlabs Option Chain
    Dr. Lal Pathlabs Financials
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 476532480431
    Operating Expenses Qtr Cr 346369344315
    Operating Profit Qtr Cr 130163136116
    Depreciation Qtr Cr 19191821
    Interest Qtr Cr 7778
    Tax Qtr Cr 31383227
    Net Profit Qtr Cr 881139471
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 1,816
    Operating Expenses Annual Cr 1,308
    Operating Profit Annual in Cr 461
    Depreciation Cr 82
    Interest Annual Cr 34
    Tax Annual Cr 98
    Net Profit Annual Cr 292
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 428
    Cash from Investing Activity Annual Cr -288
    Cash from Financing Annual Activity Cr -270
    Net Cash Flow Annual Cr -131
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 1,690
    Fixed Assets Annual Cr 366
    Total Non Current Assets Annual Cr 1,510
    Total Current Assets Annual Cr 810
    Total Assets Annual Cr 2,320
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 203
    ROE Annual % 17
    ROCE Annual % 23
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 29
    Sign Up to Know More
    IndicatorDec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 539601541491
    Operating Expenses Qtr Cr 398424395375
    Operating Profit Qtr Cr 141178146116
    Depreciation Qtr Cr 36363538
    Interest Qtr Cr 7889
    Tax Qtr Cr 34423426
    Net Profit Qtr Cr 811098357
    Sign Up to Know More
    IndicatorMar 2023
    Total Revenue Annual Cr 2,059
    Operating Expenses Annual Cr 1,527
    Operating Profit Annual in Cr 490
    Depreciation Cr 150
    Interest Annual Cr 38
    Tax Annual Cr 103
    Net Profit Annual Cr 239
    Sign Up to Know More
    IndicatorMar 2023
    Cash from Operating Activity Annual Cr 456
    Cash from Investing Activity Annual Cr -287
    Cash from Financing Annual Activity Cr -283
    Net Cash Flow Annual Cr -114
    Sign Up to Know More
    IndicatorMar 2023
    Total ShareHolders Funds Annual Cr 1,666
    Fixed Assets Annual Cr 762
    Total Non Current Assets Annual Cr 1,412
    Total Current Assets Annual Cr 973
    Total Assets Annual Cr 2,386
    Sign Up to Know More
    IndicatorMar 2023
    Book Value Per Share Annual Rs 204
    ROE Annual % 14
    ROCE Annual % 20
    Total Debt to Total Equity Annual -
    EBDIT Annual Margin % 26
    Sign Up to Know More
    Invest in Dr. Lal Pathlabs

    Dr. Lal Pathlabs Technicals

    EMA & SMA

    Current Price
    ₹2,326.75
    6.7 (0.29%)
    pointer
    • Bullish Moving Average
    • ___
    • 11
    • Bearish Moving Average
    • ___
    • 5
    • 20 Day
    • ₹2,262.35
    • 50 Day
    • ₹2,299.57
    • 100 Day
    • ₹2,355.40
    • 200 Day
    • ₹2,360.96
    • 20 Day
    • ₹2,206.66
    • 50 Day
    • ₹2,304.67
    • 100 Day
    • ₹2,433.59
    • 200 Day
    • ₹2,407.42

    Dr. Lal Pathlabs Resistance and Support

    PIVOT
    ₹2,320.15
    Resistance
    First Resistance 2,358.30
    Second Resistance 2,396.55
    Third Resistance 2,434.70
    RSI 57.70
    MFI 87.00
    MACD Single Line -3.36
    MACD 18.57
    Support
    First Resistance 2,281.90
    Second Resistance 2,243.75
    Third Resistance 2,205.50

    Dr. Lal Pathlabs Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 221,964 6,363,708 28.67
    Week 324,923 11,557,511 35.57
    1 Month 360,539 17,518,598 48.59
    6 Month 268,679 11,456,488 42.64

    Dr. Lal Pathlabs Result Highlights

    Dr. Lal Pathlabs Synopsis

    NSE-Medical-Services

    Dr. Lal Pathlabs Ltd is involved in the business activities of Other human health activities. Company’s Total Operating Revenue is Rs. 1769.03 Cr. and Equity Capital is Rs. 83.37 Cr. for the Year ended 31/03/2023. Dr. Lal Pathlabs Ltd. is a Public Limited Listed company incorporated on 14/02/1995 and has its registered office in the State of Delhi, India. Company’s Corporate Identification Number(CIN) is L74899DL1995PLC065388 and registration number is 065388.
    Market Cap 19,367
    Sales 1,919
    Shares in Float 3.76
    No of funds 320
    Yield 1.02
    Book Value 11.46
    U/D Vol ratio 0.5
    LTDebt / Equity 5
    Alpha -0.03
    Beta 0.99

    Dr. Lal Pathlabs

    Owner NameDec-23Sep-23Jun-23
    Promoters 54.6%54.61%55.01%
    Mutual Funds 5.88%5.36%4.92%
    Insurance Companies 2.73%2.61%2.41%
    Foreign Portfolio Investors 25.36%24.35%23.27%
    Financial Institutions/ Banks
    Individual Investors 7.26%8.37%9.31%
    Others 4.17%4.7%5.08%

    Dr. Lal Pathlabs Management

    Name Designation
    Brig.(Hony) Dr. Arvind Lal Executive Chairman
    Dr. Om Prakash Manchanda Managing Director
    Dr. Vandana Lal Executive Director
    Mr. Rahul Sharma Non Executive Director
    Dr. Archana Lal Erdmann Non Executive Director
    Mr. Sunil Varma Lead Independent Director
    Mr. Anoop Mahendra Singh Independent Director
    Mr. Harneet Singh Chandhoke Independent Director
    Dr. Saurabh Srivastava Independent Director
    Mrs. Somya Satsangi Independent Director
    Mr. Rohit Bhasin Independent Director
    Mr. Arun Duggal Independent Director
    Mr. Gurinder Singh Kalra Independent Director
    Mr. Rajit Mehta Independent Director

    Dr. Lal Pathlabs Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Dr. Lal Pathlabs Corporate Action

    Date Purpose Remarks
    2024-02-01 Quarterly Results & Interim Dividend
    2023-11-02 Quarterly Results
    2023-07-27 Quarterly Results & Interim Dividend
    2023-05-11 Audited Results & Final Dividend
    2023-02-02 Quarterly Results
    Date Purpose Remarks
    2024-02-13 INTERIM Rs.12.00 per share(120%)Interim Dividend
    2023-08-11 FINAL Rs.6.00 per share(60%)Final Dividend
    2023-08-11 INTERIM Rs.6.00 per share(60%)Interim Dividend
    2022-08-09 INTERIM Rs.6.00 per share(60%)Interim Dividend
    2022-06-23 FINAL Rs.6.00 per share(60%)Final Dividend

    Dr. Lal Pathlabs MF Shareholding

    Name Amount(cr)
    HDFC Balanced Advantage Fund Growth 78,759
    Kotak Equity Arbitrage Fund Growth 40,051
    SBI Arbitrage Opportunities Fund Regular Growth 27,586
    UTI Flexi Cap Fund Regular Plan Growth 24,504
    SBI Large & Midcap Fund Regular Payout Inc Dist cum Cap Wdrl 21,270

    Dr. Lal Pathlabs FAQs

    What is Share Price of Dr. Lal Pathlabs ?

    Dr. Lal Pathlabs share price is ₹2,326 As on 16 April, 2024 | 09:23

    What is the Market Cap of Dr. Lal Pathlabs ?

    The Market Cap of Dr. Lal Pathlabs is ₹19423.2 Cr As on 16 April, 2024 | 09:23

    What is the P/E ratio of Dr. Lal Pathlabs ?

    The P/E ratio of Dr. Lal Pathlabs is 58.9 As on 16 April, 2024 | 09:23

    What is the PB ratio of Dr. Lal Pathlabs ?

    The PB ratio of Dr. Lal Pathlabs is 11.4 As on 16 April, 2024 | 09:23

    Q2FY23

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.